SNAP Stays Afloat Amid Shutdown Crisis
The Daily Brief — November 3, 2025
A concise, nonpartisan roundup of what genuinely moved in the last 24 hours across the U.S., the world, science, technology, and business.
US News
Courts press USDA to keep SNAP flowing during shutdown
- Two federal judges ordered the administration to use contingency funds to continue Supplemental Nutrition Assistance Program payments despite the funding lapse; USDA must report compliance plans, though timing and amounts may vary by state. (reuters.com)
- States have warned of delays; North Carolina’s health department said November benefits would be off-schedule absent federal funds. (ncdhhs.gov)
Air travel disruptions widening
- FAA staffing shortfalls tied to unpaid controllers have triggered recurring ground stops and extended waits at several major airports, with officials warning of worse delays if the shutdown persists. (investing.com)
Political stance unchanged
- President Trump reiterated he won’t negotiate until Democrats vote to reopen the government, keeping the shutdown in week six. (apnews.com)
Why it matters (Munger lens): policy risk is directly impinging on real-economy throughput (air travel) and low‑income consumption (SNAP), two inputs to near‑term earnings quality in staples, airlines, airports, and grocers.
Global News
OPEC+ pauses planned Q1 2026 hikes; oil edges up
- The alliance kept a modest December +137k bpd increase but suspended further hikes in Q1 on surplus risks; Brent hovered near $65 and WTI near $61. (reuters.com)
- Banks are revising forward curves: Morgan Stanley lifted its H1 2026 Brent forecast to $60, citing the pause and new U.S./EU sanctions on Russian oil firms. (reuters.com)
Ukraine strikes Russian Black Sea oil infrastructure
- Drones ignited fires at Tuapse’s oil terminal; at least one vessel was damaged, according to regional reports and Ukrainian sources. Market implications include incremental logistics risk for Russian product exports. (spokesman.com)
Why it matters: supply management plus infrastructure risk keeps a volatility floor under energy, even as surplus fears persist—important for transport, chemicals, and margins across energy‑intensive industries.
Science
FDA surprise for Huntington’s gene therapy
- The FDA told uniQure that Phase I/II data for AMT‑130 are inadequate for a U.S. filing now, sending shares sharply lower and resetting timelines in a high‑profile neurodegenerative program. (reuters.com)
New data on interstellar comet 3I/ATLAS
- JWST-linked analyses suggest a radiation‑altered outer crust that could mask primordial composition; spacecraft flybys this week remain the best shot at fresh material. (livescience.com)
Why it matters: for biopharma, regulatory “goal‑post” shifts are a reminder to anchor on probability‑weighted outcomes; for space science, rare interstellar samples can reshuffle formation models—small odds, high insight.
Technology
US tightens rhetoric on top AI chips
- President Trump signaled Nvidia’s most advanced Blackwell chips should stay in the U.S., reinforcing an already‑restrictive export posture. Expect continued tension around “de‑rated” export SKUs. (reuters.com)
OpenAI–Microsoft tie-up remains in focus
- Media reports last week highlighted a restructured OpenAI governance/finance setup alongside a renewed long‑term pact with Microsoft; stakes and terms remain a moving target and bear watching for hyperscaler–model provider economics. (windowscentral.com)
Why it matters: compute chokepoints and policy risk are dictating who captures AI economics—chip vendors, hyperscalers, or applications—shaping capex cycles and margins.
Business & Markets
Oil and energy equities: cautious bid
- Crude firmed modestly after OPEC+ signaled a Q1 pause; analysts framed the move as pre‑empting surplus risk amid record U.S. output. (reuters.com)
Earnings watch: AI bellwethers on deck
- Palantir reports after the bell today (Nov 3); options imply a double‑digit move, with focus on U.S. commercial growth and AIP uptake. Qualcomm follows Wednesday (Nov 5). (tipranks.com)
Notable single‑name move
- uniQure’s pre‑market collapse on FDA feedback (above) underscores binary risk in small/mid‑cap biotech and potential spillover into gene therapy sentiment. (reuters.com)
Why it matters: near‑term leadership remains tied to AI monetization proof points and energy discipline, while regulatory turns can create acute dispersion in healthcare.
What might interest a Munger‑style investor
Policy uncertainty is a tangible cost: the shutdown’s SNAP rulings and FAA disruptions show how legal and operational frictions translate into consumption and throughput risk; look for knock‑ons in grocery comps, airline CASM/RASM, and airport retailers. (reuters.com)
Energy’s “managed surplus”: OPEC+ is trying to pre‑empt glut dynamics without ceding share; forward curves and sanctions flow‑through argue for selectivity—own low‑cost, balance‑sheet‑disciplined producers and midstream with resilient volumes. (reuters.com)
Compute geopolitics sets margins: export lines around Blackwell‑class chips and hyperscaler–model partnerships will determine where value accrues across the stack; prefer businesses with differentiated moats beyond pure hardware availability. (reuters.com)
Key dates
- Today, Nov 3: Palantir Q3 after close. (nasdaq.com)
- Wed, Nov 5: Qualcomm FQ4 after close. (investor.qualcomm.com)
Sources are linked inline.